46182-58-5Relevant articles and documents
Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents
Wang, Apeng,Xu, Shijie,Chai, Yun,Xia, Guimin,Wang, Bin,Lv, Kai,Wang, Dan,Qin, Xiaoyu,Jiang, Bin,Wu, Wenhao,Liu, Mingliang,Lu, Yu
, (2021/12/02)
Three series of novel nitrofuran-1,3,4-oxadiazole hybrids were designed and synthesized as new anti-TB agents. The structure activity relationship study indicated that the linkers and the substituents on the oxadiazole moiety greatly influence the activity, and the substituted benzenes are more favoured than the cycloalkyl or heterocyclic groups. Besides, the optimal compound in series 2 was active against both MTB H37Rv strain and MDR-MTB 16883 clinical isolate and also displayed low cytotoxicity, low inhibition of hERG and good oral PK, indicating its promising potential to be a lead for further structural modifications.
INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS
-
Page 24-25, (2010/02/10)
The present invention relates to compounds of Formula I: I which are agonists of the M-1 muscarinic receptor.